Add to ORKG! To demonstrate characteristics of polymyxin B and polymyxin E.! To introduce carbapenem-resistant gram-negative bacteria and their resistance mechanisms.! To evaluate the efficacy of polymyxins against carbapenem-resistant gram-negative bacteria.
The management of carbapenem-resistant infections is often based on polymyxins, tigecycline, aminogl...
The emergence of polymyxin resistance in carbapenem-resistant and extended-spectrum beta-lactamase (...
Malathy Krishnamurthy,1 Margaret M Lemmon,1 Evan M Falcinelli,1 Reuel A Sandy,1 Jennifer N Dootz,1 T...
Humanity is facing an enormous and growing worldwide threat from the emergence of multi-drug-resista...
Introduction: Gram negative bacilli are the important causes of common clinical infections. Carbapen...
Antimicrobial resistance represents a serious threat for global health, causing an unacceptable burd...
Carbapenem-resistant Enterobacteriaceae is a growing problem. Not only are they resistant against ca...
Infections caused by multidrug-resistant Gram-negative organisms have become a global threat. Such i...
International audiencePolymyxins are polycationic antimicrobial peptides that are currently the last...
Las enterobacterias resistentes a carbapenémicos (CRE) se han extendido por todo el mundo en las últ...
Carbapenem resistance in gram-negative bacteria has caused a global epidemic that continues to grow...
In gram-negative bacteria, antimicrobial resistance related to beta-lactamases is a serious problem ...
Antibiotic resistance has presented a major health challenge in the world and many isolates of Enter...
Polymyxins (polymyxin B (PMB) and polymyxin E (colistin)) are cyclic lipodecapeptide antibiotics, hi...
<p>MIC, minimum inhibitory concentration; MIC<sub>50</sub>, minimum inhibitory concentration for 50%...
The management of carbapenem-resistant infections is often based on polymyxins, tigecycline, aminogl...
The emergence of polymyxin resistance in carbapenem-resistant and extended-spectrum beta-lactamase (...
Malathy Krishnamurthy,1 Margaret M Lemmon,1 Evan M Falcinelli,1 Reuel A Sandy,1 Jennifer N Dootz,1 T...
Humanity is facing an enormous and growing worldwide threat from the emergence of multi-drug-resista...
Introduction: Gram negative bacilli are the important causes of common clinical infections. Carbapen...
Antimicrobial resistance represents a serious threat for global health, causing an unacceptable burd...
Carbapenem-resistant Enterobacteriaceae is a growing problem. Not only are they resistant against ca...
Infections caused by multidrug-resistant Gram-negative organisms have become a global threat. Such i...
International audiencePolymyxins are polycationic antimicrobial peptides that are currently the last...
Las enterobacterias resistentes a carbapenémicos (CRE) se han extendido por todo el mundo en las últ...
Carbapenem resistance in gram-negative bacteria has caused a global epidemic that continues to grow...
In gram-negative bacteria, antimicrobial resistance related to beta-lactamases is a serious problem ...
Antibiotic resistance has presented a major health challenge in the world and many isolates of Enter...
Polymyxins (polymyxin B (PMB) and polymyxin E (colistin)) are cyclic lipodecapeptide antibiotics, hi...
<p>MIC, minimum inhibitory concentration; MIC<sub>50</sub>, minimum inhibitory concentration for 50%...
The management of carbapenem-resistant infections is often based on polymyxins, tigecycline, aminogl...
The emergence of polymyxin resistance in carbapenem-resistant and extended-spectrum beta-lactamase (...
Malathy Krishnamurthy,1 Margaret M Lemmon,1 Evan M Falcinelli,1 Reuel A Sandy,1 Jennifer N Dootz,1 T...